Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Name: Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
SKU: 2801
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 1 Articles Tags: adverse-events, antipsychotic, cytochrome-p-450, drug-interactions, hepatic, md-deanna-l-kelly, psychotropic, robert-r-conley

Description

Description

Robert R. Conley, MD

DRUG DISPOSITION & PHARMACOKINETICS

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Robert R. Conley, MD and Deanna L. Kelly, PharmD, BCPP

PB-40-1-07-Conley

Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Description

Robert R. Conley, MD

DRUG DISPOSITION & PHARMACOKINETICS

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Robert R. Conley, MD and Deanna L. Kelly, PharmD, BCPP

C. Lindsay DeVane, PharmD: Psychoactive Drug Interactions With Pharmacotherapy for Diabetes

Antipsychotic Induced Symptomatic Hyperprolactinemia

Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia

Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR

Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Description

Robert R. Conley, MD

DRUG DISPOSITION & PHARMACOKINETICS

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Robert R. Conley, MD and Deanna L. Kelly, PharmD, BCPP

Related products

C. Lindsay DeVane, PharmD: Psychoactive Drug Interactions With Pharmacotherapy for Diabetes

Antipsychotic Induced Symptomatic Hyperprolactinemia

Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia

Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR